- Current report filing (8-K)
June 09 2011 - 12:12PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 9, 2011 (June 9, 2011)
TOMOTHERAPY INCORPORATED
(Exact name of registrant as specified in its charter)
Wisconsin
|
|
001-33452
|
|
39-1914727
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1240 Deming Way
Madison, Wisconsin 53717
(Address of principal executive offices) (zip code)
(608) 824-2800
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders.
As previously disclosed, on March 6, 2011, TomoTherapy Incorporated (TomoTherapy) entered into an Agreement and Plan of Merger with Accuray Incorporated and Jaguar Acquisition, Inc. (the Merger Agreement). On June 9, 2011, at a special meeting of the shareholders of TomoTherapy (the Special Meeting), TomoTherapys shareholders voted to approve and adopt the Merger Agreement. A summary of the voting results is set forth below:
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
|
44,487,817
|
|
745,152
|
|
14,483
|
|
In connection with the Special Meeting, TomoTherapy also solicited proxies with respect to a proposal to adjourn the Special Meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in the event there were insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement. The adjournment proposal, which was unnecessary in light of the approval and adoption of the Merger Agreement by TomoTherapys shareholders as indicated above, was withdrawn and not submitted to a vote of TomoTherapys shareholders at the Special Meeting.
A copy of the press release announcing the approval and adoption of the Merger Agreement by the shareholders of TomoTherapy is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
Number
|
|
Description
|
99.1
|
|
Press Release dated June 9, 2011
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
TOMOTHERAPY INCORPORATED
|
|
|
|
|
By:
|
/s/ Thomas E. Powell
|
|
Name:
|
Thomas E. Powell
|
|
Title:
|
Chief Financial Officer and Treasurer
|
Date: June 9, 2011
3
EXHIBIT INDEX
Number
|
|
Description
|
99.1
|
|
Press Release dated June 9, 2011
|
4
Tom Online (NASDAQ:TOMO)
Historical Stock Chart
From May 2024 to Jun 2024
Tom Online (NASDAQ:TOMO)
Historical Stock Chart
From Jun 2023 to Jun 2024